Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulse Biosciences (PLSE) Payables (2020 - 2025)

Historic Payables for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $3.0 million.

  • Pulse Biosciences' Payables rose 7243.78% to $3.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year increase of 7243.78%. This contributed to the annual value of $1.7 million for FY2024, which is 887.8% down from last year.
  • Per Pulse Biosciences' latest filing, its Payables stood at $3.0 million for Q3 2025, which was up 7243.78% from $2.7 million recorded in Q2 2025.
  • In the past 5 years, Pulse Biosciences' Payables registered a high of $4.6 million during Q2 2021, and its lowest value of $1.4 million during Q3 2023.
  • Over the past 5 years, Pulse Biosciences' median Payables value was $2.3 million (recorded in 2021), while the average stood at $2.4 million.
  • As far as peak fluctuations go, Pulse Biosciences' Payables skyrocketed by 20577.57% in 2021, and later tumbled by 5721.5% in 2022.
  • Pulse Biosciences' Payables (Quarter) stood at $2.3 million in 2021, then rose by 9.6% to $2.5 million in 2022, then fell by 26.27% to $1.8 million in 2023, then fell by 8.88% to $1.7 million in 2024, then soared by 78.0% to $3.0 million in 2025.
  • Its last three reported values are $3.0 million in Q3 2025, $2.7 million for Q2 2025, and $2.4 million during Q1 2025.